Inhibition of microRNA-25 by tumor necrosis factor α is critical in the modulation of vascular smooth muscle cell proliferation

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4353-4358

  Qi, Lichun ^a   Zhi, Jixin ^a   Zhang, Tong ^a   Cao, Xue ^a   Sun, Lixiu ^a   Xu, Yuanyuan ^a   Li, Xueqi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; MicroRNA; MicroRNA 25; Proliferation; Tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; JANUS KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; 3' UNTRANSLATED REGION; CYCLIN DEPENDENT KINASE 6; MICRORNA; MIRN25 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER CELL; CANCER STEM CELL; CELL CONTACT; CELL DIFFERENTIATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; M2 MACROPHAGE; MACROPHAGE; MOLECULAR INTERACTION; OVARIAN CANCER STEM LIKE CELL; OVARY CANCER; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION; 3' UNTRANSLATED REGION; BINDING SITE; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 6; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RNA INTERFERENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924705872     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3329     Document Type: Article

References (47)

1. Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S and Karmazyn M: Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II-and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Ther 315: 1075-1084, 2005.
2. Chen NX, Kiattisunthorn K, O'Neill KD, et al: Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PloS One 8: e64558, 2013.
3. Davis-Dusenbery BN, Wu C and Hata A: Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol 31: 2370-2377, 2011.
4. Kothapalli D, Castagnino P, Rader DJ, Phillips MC, Lund-Katz S and Assoian RK: Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222. Atherosclerosis 227: 65-71, 2013.
5. Bohlen F, Kratzsch J, Mueller M, et al: Leptin inhibits cell growth of human vascular smooth muscle cells. Vascul Pharmacol 46: 67-71, 2007.
6. Bodary PF, Shen Y, Ohman M, et al: Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 27: 70-76, 2007.
7. Beltowski J: Leptin and atherosclerosis. Atherosclerosis 189: 47-60, 2006.
8. Davis R, Pillai S, Lawrence N, Sebti S and Chellappan SP: TNF-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes. Cell Cycle 11: 109-118, 2012.
9. Gao X, Belmadani S, Picchi A, et al: Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115: 245-254, 2007.
10. Rajesh M, Mukhopadhyay P, Haskó G, Huffman JW, Mackie K and Pacher P: CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol 153: 347-357, 2008.
11. Lee SJ, Kim WJ and Moon SK: TNF-alpha regulates vascular smooth muscle cell responses in genetic hypertension. Int Immunopharmacol 9: 837-843, 2009.
12. Rho MC, Ah Lee K, Mi Kim S, et al: Sensitization of vascular smooth muscle cell to TNF-alpha-mediated death in the presence of palmitate. Toxicol Appl Pharmacol 220: 311-319, 2007.
13. Song B, Wang Y, Xi Y, et al: Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28: 4065-4074, 2009.
14. Yu X, Li Z, Shen J, et al: MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PloS One 8: e83080, 2013.
15. Hutcheson R, Terry R, Chaplin J, et al: MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol 33: 727-736, 2013.
16. Martello G, Rosato A, Ferrari F, et al: A MicroRNA targeting dicer for metastasis control. Cell 141: 1195-1207, 2010.
17. Majid S, Dar AA, Saini S, et al: MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PloS One 8: e67686, 2013.
18. Wu WK, Lee CW, Cho CH, et al: MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29: 5761-5771, 2010.
19. Brenner B, Hoshen MB, Purim O, et al: MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 17: 3976-3985, 2011.
20. Cullen BR: MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 14: 205-210, 2013.
21. Rotllan N and Fernández-Hernando C: MicroRNA regulation of cholesterol metabolism. Cholesterol 2012: 847849, 2012.
22. Chen KC and Juo SH: MicroRNAs in atherosclerosis. Kaohsiung J Med Sci 28: 631-640, 2012.
23. Chen LJ, Lim SH, Yeh YT, Lien SC and Chiu JJ: Roles of microRNAs in atherosclerosis and restenosis. J Biomed Sci 19: 79, 2012.
24. Sun Y, Chen D, Cao L, et al: MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A. Cardiovasc Res 100: 272-279, 2013.
25. Yu ML, Wang JF, Wang GK, et al: Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J 75: 703-709, 2011.
26. Kim S and Kang H: miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep 46: 550-554, 2013.
27. Li P, Liu Y, Yi B, et al: MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 99: 185-193, 2013.
28. Gómez-Hernández A, Escribano Ó, Perdomo L, et al: Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF and IGF-II. Endocrinology 154: 2352-2364, 2013.
29. Jiang F, Jiang R, Zhu X, Zhang X and Zhan Z: Genipin inhibits TNF-induced vascular smooth muscle cell proliferation and migration via induction of HO-1. PloS One 8: e74826, 2013.
30. Kim HH and Kim K: Enhancement of TNF-alpha-mediated cell death in vascular smooth muscle cells through cytochrome c-independent pathway by the proteasome inhibitor. FEBS Lett 535: 190-194, 2003.
31. Li Q, Zou C, Han Z, et al: MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett 335: 168-174, 2013.
32. Razumilava N, Bronk SF, Smoot RL, et al: miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 55: 465-475, 2012.
33. Lu D, Davis MP, Abreu-Goodger C, et al: MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PloS One 7: e40938, 2012.
34. Su ZX, Zhao J, Rong ZH, Geng WM, Wu YG and Qin CK: Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagn Pathol 9: 47, 2014.
35. Xu FX, Su YL, Zhang H, Kong JY, Yu H and Qian BY: Prognostic implications for high expression of MiR-25 in lung adenocarcinomas of female non-smokers. Asian Pac J Cancer Prev 15: 1197-1203, 2014.
36. Esposito F, Tornincasa M, Pallante P, et al: Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 97: E710-E718, 2012.
37. Li X, Yang C, Wang X, Zhang J, Zhang R and Liu R: The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis. Med Oncol 31: 781, 2014.
38. Wahlquist C, Jeong D, Rojas-Muñoz A, et al: Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 508: 531-535, 2014.
39. Setyowati Karolina D, Sepramaniam S, Tan HZ, Armugam A and Jeyaseelan K: miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA Biol 10: 1365-1378, 2013.
40. Zhang H, Zuo Z, Lu X, Wang L, Wang H and Zhu Z: MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 27: 594-598, 2012.
41. Grossel MJ and Hinds PW: Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 97: 485-493, 2006.
42. Pauls E, Ruiz A, Badia R, et al: Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol 193: 1988-1997, 2014.
43. Kohrt D, Crary J, Zimmer M, et al: CDK6 binds and promotes the degradation of the EYA2 protein. Cell Cycle 13: 62-71, 2014.
44. Wu J, Qian J, Li C, et al: miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9: 1809-1818, 2010.
45. Dauphinot L, De Oliveira C, Melot T, et al: Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 20: 3258-3265, 2001.
46. Kollmann K and Sexl V: CDK6 and p16INK4A in lymphoid malignancies. Oncotarget 4: 1858-1859, 2013.
47. Liu B, Han M, Sun RH, Wang JJ, Liu YP and Wen JK: Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells. Int J Cardiol 149: 30-38, 2011.